29.07.2016 • NewsCornelius GroupPeopleNeville Prior

Darren Spiby Appointed as CEO of Cornelius

SpibyDarren, the new CEO of Cornelius
SpibyDarren, the new CEO of Cornelius

Darren Spiby, to date Cornelius managing director, has been promoted to the role of CEO. With this organizational change his former role will cease to exist.

Spiby will be continuing to report to the previous holder of the position, Dr. Neville Prior, who remains as chairman of the board.

Spiby has worked with Cornelius for 12 years. He first joined the company as a new business development manager in 2004 and has since lead teams to develop new business in the health and nutrition, care products and industrial sectors in the UK and Europe.

His new role includes the development of a solid framework for future business growth, with a focus on the identification and delivery of synergies between the Cornelius distribution and specialty manufacturing businesses.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read